Cadonilimab Combined With Liposomal Irinotecan Plus Leucovorin and Fluorouracil for Advanced Cholangiocarcinoma

NCT06438822 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

51

Enrollment

OTHER

Sponsor class

Conditions

Cholangiocarcinoma

Interventions

COMBINATION_PRODUCT: Cadonilimab Combined With Liposomal Irinotecan Plus Leucovorin and Fluorouracil

Sponsor

West China Hospital